Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Congenital alpha2 antiplasmin deficiency is a rare hemorrhagic disorder caused by congenital deficiency of alpha2 antiplasmin, leading to dysregulated fibrinolysis and is characterized by a hemorrhagic tendency presenting from childhood with prolonged bleeding and ecchymoses following minor trauma and spontaneous bleeding episodes (often in unusual locations like diaphysis of long bones). Congenital alpha2 antiplasmin deficiency is inherited in an autosomal recessive manner.
Features include very common findings: Joint hemorrhage and Persistent bleeding after trauma; and common findings: Hemothorax, Blood in the urine (hematuria), Abnormal bleeding tendency (abnormal bleeding), and Intramuscular hematoma and others. 12 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 4 | Persistent bleeding after trauma, Abnormal bleeding tendency (abnormal bleeding), Gingival bleeding |
SERPINF2 function has not been fully characterized.
Alpha-2-plasmin inhibitor deficiency is caused by mutations in the SERPINF2 gene on chromosome 17.
Genetic testing for SERPINF2 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 very common features, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for alpha-2-plasmin inhibitor deficiency.
3 publications have been identified in PubMed for alpha-2-plasmin inhibitor deficiency. Research spans Case Report / Case Series (67%) and Basic Science / Preclinical (33%).
Murray A (2026). [PMID: 41076373](https://pubmed.ncbi.nlm.nih.gov/41076373/). *Journal of cardiothoracic and vascular anesthesia*. [Case Report / Case Series]
Kilpatrick K (2025). [PMID: 40470612](https://pubmed.ncbi.nlm.nih.gov/40470612/). *Journal of veterinary internal medicine*. [Basic Science / Preclinical]
Miyahara S (2025). [PMID: 40589561](https://pubmed.ncbi.nlm.nih.gov/40589561/). *Surgical case reports*. [Case Report / Case Series]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 1:06 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Bones and joints | 2 | Joint hemorrhage, Bone pain |
Kidneys and urinary system | 1 | Blood in the urine (hematuria) |
Heart and blood vessels | 1 | Intracranial hemorrhage |